ALNA

Allena Pharmaceuticals, Inc. Common Stock
ALNA

Overview Fund Activity
Delisted

ALNA was delisted on the 7th of September, 2022.

Back to rankings

29 hedge funds and large institutions have $28.1M invested in Allena Pharmaceuticals, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 4 closing their positions.

Holders
29
Holders Change
-1
Holders Change %
-3.33%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
10
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.55M
2
Morgan Stanley
2
Morgan Stanley
New York
$1.36M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$911K
4
Millennium Management
4
Millennium Management
New York
$244K
5
KAS
5
Kestra Advisory Services
Texas
$95K

Top Sellers

1
WVP
1
Worth Venture Partners
New Jersey
$967K
2
Two Sigma Advisers
2
Two Sigma Advisers
New York
$0
3
Two Sigma Investments
3
Two Sigma Investments
New York
$0
4
BCM
4
Bridgeway Capital Management
Texas
$456K
5
HF
5
HRT Financial
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
HI
26
Harbour Investments
Wisconsin
$7K +$3.18K +2,500 +83%
TRCT
27
Tower Research Capital (TRC)
New York
$5K +$4.85K +3,813 +3,125%
UBS Group
28
UBS Group
Switzerland
$3K -$8.73K -7,274 -74%
Wells Fargo
29
Wells Fargo
California
$1K +$25 +31 +3%
Two Sigma Advisers
30
Two Sigma Advisers
New York
– -$192K -137,900 Closed
Two Sigma Investments
31
Two Sigma Investments
New York
– -$56K -40,200 Closed
HF
32
HRT Financial
New York
– -$31K -22,382 Closed
Barclays
33
Barclays
United Kingdom
– -$13K -9,019 Closed
1
2